Berberine Inhibits the Adhesion of Candida albicans to Vaginal Epithelial Cells

Berberine Inhibits the Adhesion of Candida albicans to Vaginal Epithelial Cells

Vulvovaginal candidiasis (VVC) is an inflammatory disease of the vagina mainly caused by Candida albicans (C. albicans), which affects around three-quarters of all women during their reproductive age. Although some antifungal drugs such as azoles have been applied clinically for many years, their th...

Full description

Bibliographic Details
Main Authors:	Ting Zhao, Kang Zhang, Gaoxiang Shi, Kelong Ma, Benfan Wang, Jing Shao, Tianming Wang, Changzhong Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Pharmacology
Subjects:	Berberine Candida albicans vaginal epithelial cells vulvovaginal candidiasis adhesion
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.814883/full

Similar Items

Physical Interaction of Sodium Houttuyfonate With β-1,3-Glucan Evokes Candida albicans Cell Wall Remodeling
by: Wenyue Da, et al.
Published: (2019-01-01)

Decreasing Cell Population of Individual Candida Species Does Not Impair the Virulence of Candida albicans and Candida glabrata Mixed Biofilms
by: Qianqian Li, et al.
Published: (2019-07-01)

The fungal quorum-sensing molecule, farnesol, regulates the immune response of vaginal epithelial cells against Candida albicans
by: Ting Li, et al.
Published: (2023-09-01)

Extraction of Extracellular Matrix in Static and Dynamic Candida Biofilms Using Cation Exchange Resin and Untargeted Analysis of Matrix Metabolites by Ultra-High-Performance Liquid Chromatography-Tandem Quadrupole Time-of-Flight Mass Spectrometry (UPLC-Q-TOF-MS)
by: Wenyue Da, et al.
Published: (2019-04-01)

<i>Candida albicans</i> Infection Disrupts the Metabolism of Vaginal Epithelial Cells and Inhibits Cellular Glycolysis
by: Yanni Zhao, et al.
Published: (2024-01-01)

Systems pharmacology and transcriptomics reveal the mechanisms of Sanhuang decoction enema in the treatment of ulcerative colitis with additional Candida albicans infection
by: Zhijun Han, et al.
Published: (2021-08-01)

Recombinant Human IFNα-2b Response Promotes Vaginal Epithelial Cells Defense against Candida albicans
by: Zhaohui Liu, et al.
Published: (2017-04-01)

Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms
by: Mengli Chen, et al.
Published: (2022-12-01)

Genotypic analysis of secreted aspartyl proteinases in vaginal Candida albicans isolates
by: Janaína S. Lima, et al.
Published: (2018-02-01)

Vaginal Candidiasis among Pregnant Women in Ebonyi State, South East Nigeria.
by: Chito Clare Ekwealor, et al.
Published: (2023-09-01)

Prevalence of Closely Related Candida albicans Species among Patients with Vulvovaginal Candidiasis in Southern Poland Based on the hwp1 Gene Amplification
by: KLESIEWICZ KAROLINA, et al.
Published: (2023-03-01)

Interpretation of vaginal metagenomic characteristics in different types of vaginitis
by: Jiarong Song, et al.
Published: (2024-03-01)

Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Candida Species and Efflux-Associated Antifungal Mechanism
by: Tianming Wang, et al.
Published: (2018-12-01)

Clinical <italic toggle="yes">Candida albicans</italic> Vaginal Isolates and a Laboratory Strain Show Divergent Behaviors during Macrophage Interactions
by: Franziska Gerwien, et al.
Published: (2020-08-01)

Design and evaluation of antifungal vaginal suppository using coconut oil as base for vulvovaginal candidiasis
by: Ayomide D. Mustapha, et al.
Published: (2023-09-01)

Synergistic Antifungal Effect of Fluconazole Combined with ZnO Nanoparticles against Candida albicans Strains from Vaginal Candidiasis
by: Azadeh abedzadeh hajar, et al.
Published: (2020-05-01)

Risk Factors and Health Hazards of Vaginal Infections in Upper Egypt: A Cross Sectional Study
by: Ahmed M. Abbas, et al.
Published: (2016-03-01)

Investigation of the Effect of Gold Nanoparticles on Vital Factors of Isolated Candida albicans in Patients with Vulvovaginal Candidiasis In Vitro
by: J Alipoor, et al.
Published: (2015-06-01)

Recurrent vaginal discharge
by: Marcos Takimura, et al.
Published: (2018-10-01)

Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection
by: Yufei Wang, et al.
Published: (2024-03-01)

Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran
by: Seddigheh Esmaeilzadeh, et al.
Published: (2009-08-01)

Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India
by: Varsha Kumari, et al.
Published: (2013-01-01)

Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis
by: Wenhui Qi, et al.
Published: (2021-11-01)

The Antifungal Effect of the Fraction Isolated from Allium Hirtifolium Extract on Vaginal Candidiasis in Comparison with Clotrimazole: A Double-Blind Clinical Trial Study
by: ‪Mansour Amin, et al.
Published: (2022-01-01)

Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis
by: Bingbing Xiao, et al.
Published: (2022-03-01)

Drug Resistance and Biofilm Formation in Candida Species of Vaginal Origin
by: Tahereh Alikhani, et al.
Published: (2022-04-01)

Effect of progesterone on Candida albicans biofilm formation under acidic conditions: A transcriptomic analysis
by: Bruna Gonçalves, et al.
Published: (2020-04-01)

The Prevalence of Non-albicans Candida and Candida Mixed-species in Vulvovaginal Candidiasis in Northeast Iran
by: Batoul Jannati, et al.
Published: (2024-03-01)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
by: Jian Miao, et al.
Published: (2023-04-01)

Membrane of Candida albicans as a target of berberine
by: Nataša Zorić, et al.
Published: (2017-05-01)

Flucovag: efficacy and safety in patients with vulvovaginal candidiasis: a prospective, multicenter, open-label, randomized, comparative clinical study
by: Flora R. Kutueva, et al.
Published: (2023-04-01)

Síndrome de flujo vaginal (vaginitis / vaginosis): actualización diagnóstica y terapéutica
by: Franklin De La Hoz Espitia
Published: (2021-07-01)

The Interplay between <i>Candida albicans,</i> Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives
by: Roberta Gaziano, et al.
Published: (2023-05-01)

Correlation analysis of vaginal microecology and different types of human papillomavirus infection: a study conducted at a hospital in northwest China
by: Fang Feng, et al.
Published: (2023-06-01)

Characterization of ERG11 Gene in Drug-Resistant Candida Albicans Isolated from Iranian Cases of Recurrent Vulvovaginal Candidiasis
by: Kambiz Diba, et al.
Published: (2020-06-01)

Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome
by: Changying Zhao, et al.
Published: (2023-06-01)

Sweet Relief: Determining the Antimicrobial Activity of Medical Grade Honey Against Vaginal Isolates of <em>Candida albicans</em>
by: Renée Hermanns, et al.
Published: (2019-09-01)

Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates
by: Yi Xu, et al.
Published: (2017-11-01)

Editorial: Vaginal microecological disorder and gynecological diseases
by: Tingtao Chen, et al.
Published: (2023-10-01)

Recent Developments on Using Nanomaterials to Combat Candida albicans
by: Bingxin Li, et al.
Published: (2021-12-01)